CRBU Caribou Biosciences, Inc.

Fundamentals / CIK 0001619856 / USD

Caribou Biosciences, Inc. reported $9.44M in revenue and a net loss of $102.5M for the trailing twelve months ended September 30, 2026 (down 26.9% year over year), with a -1140.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CRBU in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$49.73M$24.86M$0-$142.3MFY 2019 Revenue: $5.79MFY 2019 Net Income: -$23.43M2019FY 2020 Revenue: $12.36MFY 2020 Net Income: -$34.31M2020FY 2021 Revenue: $9.60MFY 2021 Net Income: -$66.92M2021FY 2022 Revenue: $13.85MFY 2022 Net Income: -$99.42M2022FY 2023 Revenue: $34.48MFY 2023 Net Income: -$102.1M2023FY 2024 Revenue: $9.99MFY 2024 Net Income: -$149.1M2024FY 2025 Revenue: $11.16MFY 2025 Net Income: -$148.1M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $11.16M $9.99M $34.48M $13.85M $9.60M $12.36M $5.79M
Research & Development $109.4M $130.2M $112.1M $82.23M $52.26M $34.42M $23.64M
Total Operating Expenses $159.5M $176.6M $150.5M $120.2M $76.58M $48.48M $40.09M
Operating Income -$148.3M -$166.6M -$116.1M -$106.4M -$66.98M -$36.12M -$34.30M
EBITDA -$144.7M -$162.7M -$112.5M -$104.8M -$66.00M -$35.22M -$33.55M
Interest Income -- -- -- -- $148K $236K $1.05M
Interest Expense -- -- -- -- $8.0K $20K $4.0K
Income Before Tax -$148.7M -$149.1M -$101.9M -$99.35M -$66.60M -$36.13M -$30.97M
Income Tax Expense -$550K -$9.0K $193K $70K $321K -$1.82M -$7.54M
Net Income -$148.1M -$149.1M -$102.1M -$99.42M -$66.92M -$34.31M -$23.43M
Basic EPS -$1.59 -$1.65 -$1.38 -$1.64 -$2.11 -$4.01 -$2.80
Diluted EPS -$1.59 -$1.65 -$1.38 -$1.64 -$2.11 -$4.01 -$2.80
Basic Shares Outstanding 93.4M 90.3M 73.8M 60.8M 31.7M 8.5M 8.4M
Diluted Shares Outstanding 93.4M 90.3M 73.8M 60.8M 31.7M 8.5M 8.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.61M $1.50M $2.40M $3.94M $2.20M $2.67M $2.35M $2.08M
Research & Development $21.35M $18.94M $20.61M $23.82M $22.40M $27.69M $35.53M $30.46M
Total Operating Expenses $29.25M $26.84M $28.68M $32.39M $31.60M $50.24M $45.27M $40.95M
Operating Income -$27.64M -$25.34M -$26.28M -$28.45M -$29.40M -$47.58M -$42.91M -$38.88M
EBITDA -$27.05M -$24.71M -$25.63M -$27.77M -$28.77M -$46.41M -$41.75M -$37.69M
Income Tax Expense -- -- $0 -$550K $0 -- $0 -$9.0K
Net Income -$26.61M -$24.28M -$25.09M -$26.49M -$27.55M -$54.10M -$39.99M -$35.49M
Basic EPS -$0.25 -$0.24 -$0.26 -- -$0.30 -$0.58 -$0.43 --
Diluted EPS -$0.25 -$0.24 -$0.26 -- -$0.30 -$0.58 -$0.43 --
Basic Shares Outstanding 107.5M 101.0M 95.9M -- 93.3M 93.0M 92.7M --
Diluted Shares Outstanding 107.5M 101.0M 95.9M -- 93.3M 93.0M 92.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $12.36M $16.29M $51.16M $58.34M $240.4M $15.95M
Short-Term Investments $127.0M $193.2M $277.7M $189.3M $135.4M $0
Cash & Short-Term Investments $142.8M $249.4M $372.4M $317.0M $413.5M $15.95M
Accounts Receivable, Net $69K $265K $148K $202K $1.15M $150K
Total Current Assets $145.2M $219.4M $338.8M $260.2M $391.2M $24.31M
Property, Plant & Equipment, Net $6.76M $19.28M $18.27M $10.68M $4.89M $3.50M
Long-Term Investments $3.50M $39.85M $43.58M $69.37M $37.68M $0
Other Non-Current Assets $2.20M $5.52M $1.59M $1.54M $975K $612K
Total Non-Current Assets $30.14M $93.94M $93.37M $113.5M $51.16M $11.74M
Total Assets $175.4M $313.3M $432.2M $373.8M $442.4M $36.05M
Accounts Payable $5.78M $2.48M $3.12M $1.15M $3.99M $2.60M
Deferred Revenue (Current) $1.90M $3.13M $2.85M $9.94M $8.70M $50K
Other Current Liabilities $2.68M $1.68M $1.11M $1.37M $788K $629K
Total Current Liabilities $25.41M $30.65M $28.30M $28.13M $25.83M $12.39M
Deferred Revenue (Non-Current) $1.75M $3.32M $6.10M $15.95M $22.03M $937K
Total Non-Current Liabilities $27.78M $29.71M $35.51M $44.77M $28.70M $5.77M
Total Liabilities $53.19M $60.36M $63.81M $72.89M $54.53M $18.16M
Total Debt (incl. Leases) $27.23M $26.49M $27.11M $27.75M -- --
Common Stock $9.0K $9.0K $8.0K $6.0K $6.0K $1.0K
Retained Earnings -$596.5M -$448.4M -$299.3M -$197.2M -$97.79M -$30.87M
Accumulated Other Comp. Income $103K $255K $30K -$1.52M -$135K $0
Total Stockholders' Equity $122.2M $253.0M $368.4M $300.9M $387.8M -$23.44M
Total Equity $122.2M $253.0M $368.4M $300.9M $387.8M -$23.44M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $26.06M $26.19M $12.06M $12.36M $11.14M $25.20M $29.42M $16.29M
Short-Term Investments $68.74M $86.12M $105.6M $127.0M $136.1M $158.7M $179.0M $193.2M
Cash & Short-Term Investments $94.80M $113.8M $118.6M $142.8M $159.2M $183.9M $212.5M $249.4M
Accounts Receivable, Net $518K $203K $227K $69K $242K $71K $88K $265K
Total Current Assets $100.1M $116.6M $122.4M $145.2M $155.5M $192.5M $217.3M $219.4M
Property, Plant & Equipment, Net $4.87M $5.50M $6.12M $6.76M $7.60M $8.18M $18.52M $19.28M
Long-Term Investments $0 $1.50M $1.00M $3.50M $11.95M $0 $3.99M $39.85M
Other Non-Current Assets $1.38M $2.14M $2.14M $2.20M $3.78M $3.62M $5.04M $5.52M
Total Non-Current Assets $22.95M $26.18M $26.62M $30.14M $39.48M $28.40M $56.33M $93.94M
Total Assets $123.0M $142.8M $149.0M $175.4M $195.0M $220.9M $273.7M $313.3M
Accounts Payable $5.05M $3.08M $3.50M $5.78M $3.80M $3.24M $3.87M $2.48M
Deferred Revenue (Current) $370K $372K $994K $1.90M $2.22M $2.83M $2.83M $3.13M
Other Current Liabilities $2.03M $1.70M $732K $2.68M $1.86M $2.07M $1.54M $1.68M
Total Current Liabilities $20.14M $17.97M $19.67M $25.41M $28.06M $28.89M $28.49M $30.65M
Deferred Revenue (Non-Current) $1.37M $1.42M $1.65M $1.75M $1.76M $1.77M $2.62M $3.32M
Total Non-Current Liabilities $26.25M $26.70M $27.31M $27.78M $25.08M $25.88M $27.94M $29.71M
Total Liabilities $46.39M $44.67M $46.98M $53.19M $53.14M $54.77M $56.43M $60.36M
Total Debt (incl. Leases) $26.34M $26.66M $26.95M $27.23M $25.46M $25.85M $26.22M $26.49M
Common Stock $11K $11K $10K $9.0K $9.0K $9.0K $9.0K $9.0K
Retained Earnings -$672.5M -$645.9M -$621.6M -$596.5M -$570.0M -$542.5M -$488.4M -$448.4M
Accumulated Other Comp. Income -$80K -$71K -$23K $103K $93K $40K $167K $255K
Total Stockholders' Equity $76.63M $98.10M $102.0M $122.2M $141.8M $166.1M $217.2M $253.0M
Total Equity $76.63M $98.10M $102.0M $122.2M $141.8M $166.1M $217.2M $253.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$148.1M -$149.1M -$102.1M -$99.42M -$66.92M -$34.31M -$23.43M
Depreciation & Amortization $3.65M $3.93M $3.52M $1.62M $984K $900K $751K
Stock-Based Compensation $12.68M $16.71M $13.75M $11.72M $3.45M $1.00M $1.23M
Change in Receivables $196K -$117K $54K $951K -$1.00M -$146K $617K
Change in Payables $3.25M -$354K $1.82M -$2.72M $1.14M $43K $1.18M
Operating Cash Flow -$111.0M -$138.2M -$93.29M -$90.97M -$32.52M -$33.22M -$32.01M
Capital Expenditure -$1.36M -$4.88M -$11.61M -$6.45M -$2.12M -$317K -$884K
Free Cash Flow -$112.4M -$143.1M -$104.9M -$97.42M -$34.64M -$33.53M -$32.89M
Purchases of Investments -$149.2M -$304.4M -$394.8M -$339.1M -$173.3M $0 $0
Investing Cash Flow $102.2M $86.61M -$68.18M -$93.25M -$176.4M $6.36M $27.23M
Common Stock Issued $4.07M $15.19M $1.01M $0 -- -- --
Financing Cash Flow $4.82M $16.72M $154.3M $2.13M $433.4M $1.74M $172K
Net Change in Cash -$3.93M -$34.87M -$7.18M -$182.1M $224.5M -$25.12M -$4.60M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$26.61M -$24.28M -$25.09M -$26.49M -$27.55M -$54.10M -$39.99M -$35.49M
Depreciation & Amortization $590K $625K $649K $682K $631K $1.17M $1.17M $1.18M
Stock-Based Compensation $2.16M $2.48M $2.36M $2.74M $2.93M $3.13M $3.88M $3.91M
Change in Receivables -$315K $24K -$158K $173K -$171K $17K $177K -$81K
Change in Payables $1.97M -$423K -$2.22M $1.92M $561K -$630K $1.40M -$229K
Operating Cash Flow -$22.52M -$22.79M -$26.98M -$20.82M -$25.18M -$28.26M -$36.73M -$35.47M
Capital Expenditure -$19K -$1.0K -$72K $216K -$115K -$418K -$1.04M -$518K
Free Cash Flow -$22.54M -$22.79M -$27.06M -$20.61M -$25.30M -$28.68M -$37.77M -$35.99M
Purchases of Investments -$15.94M -$20.50M -$22.09M -$44.03M -$57.45M -$32.22M -$15.53M -$55.50M
Investing Cash Flow $19.39M $18.94M $23.98M $17.97M $10.85M $24.04M $49.38M $15.93M
Common Stock Issued $2.68M $17.92M $2.22M $4.07M $0 $0 $0 $3.86M
Financing Cash Flow $2.99M $17.94M $2.70M $4.07M $277K $6.0K $468K $3.86M
Net Change in Cash -$137K $14.09M -$303K $1.22M -$14.06M -$4.22M $13.12M -$15.68M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1329.4% -1667.2% -336.6% -768.2% -697.8% -292.2% -592.7%
Net Profit Margin -1327.4% -1491.9% -296.1% -717.8% -697.3% -277.6% -404.8%
Return on Equity (ROE) -121.2% -58.9% -27.7% -33.0% -17.3% -- --
Return on Assets (ROA) -84.5% -47.6% -23.6% -26.6% -15.1% -95.2% --
Current Ratio 5.71x 7.16x 11.97x 9.25x 15.15x 1.96x --
Quick Ratio 5.62x 8.15x 13.16x 11.28x 16.05x 1.30x --
Debt to Equity 0.22x 0.10x 0.07x 0.09x -- -- --
Revenue Growth (YoY) +11.7% -71.0% +148.9% +44.3% -22.4% +113.6% --
5Y Revenue / Share Growth -91.7% -84.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1140.6% -1090.9% -1175.7% -1329.4% -1708.1% -1837.6% -1648.8% -1667.2%
Net Profit Margin -1085.0% -1030.4% -1189.1% -1327.4% -1690.4% -1800.9% -1490.8% -1491.9%
Return on Equity (ROE) -133.7% -105.4% -130.6% -121.2% -110.8% -98.9% -68.1% -58.9%
Return on Assets (ROA) -83.3% -72.4% -89.4% -84.5% -80.6% -74.4% -54.0% -47.6%
Current Ratio 4.97x 6.49x 6.22x 5.71x 5.54x 6.66x 7.63x 7.16x
Quick Ratio 4.73x 6.34x 6.04x 5.62x 5.68x 6.37x 7.46x 8.15x
Debt to Equity 0.34x 0.27x 0.26x 0.22x 0.18x 0.16x 0.12x 0.10x
Revenue Growth (YoY) -26.9% -43.8% +1.9% +89.7% +8.6% -23.0% -3.1% -41.6%
Source: SEC EDGAR CompanyFacts (CIK 0001619856) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal